Literature DB >> 6174863

Stage specific protein and nucleic acid synthesis during the asexual cycle of the rodent malaria Plasmodium chabaudi.

C I Newbold, D B Boyle, C C Smith, K N Brown.   

Abstract

The asexual, intraerythrocytic stage of Plasmodium chabaudi develops synchronously in CBA mice. This in vivo synchrony has been exploited in in vitro pulse-labelling experiments to investigate the stage specificity of macromolecular synthesis by malaria parasites. Groups of mice were infected on day 0 with P. chabaudi and on day 3, individual mice were killed at three hour intervals, and the parasitised blood labelled in vitro for 2 h with radioactive precursors of protein or nucleic acid synthesis. By taking 11 samples covering one and one-third parasite division cycles, it was shown that the synthesis of many parasite polypeptides was restricted to defined morphological stages of parasite development. Other polypeptides were synthesised more or less continuously during the growth cycle. The synthesis of at least 6 polypeptides was confined to schizont or merozoite differentiation. RNA synthesis was shown to increase in rate steadily during parasite growth and to fall sharply during merozoite invasion. Approximately 40% of DNA synthesis was shown to occur during trophozoite growth, but the majority (60%) was confined to a short 4-6 h period at or just before schizogony.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6174863     DOI: 10.1016/0166-6851(82)90004-4

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  11 in total

1.  Quantification of the alpha and beta subunits of the transducing elements (Gs and Gi) of adenylate cyclase in adipocyte membranes from lean and obese (ob/ob) mice.

Authors:  N Bégin-Heick
Journal:  Biochem J       Date:  1990-05-15       Impact factor: 3.857

2.  Cardiac mRNA levels during the development and growth of the rat.

Authors:  P M Garber; V A Mezl
Journal:  Basic Res Cardiol       Date:  1988 Jul-Aug       Impact factor: 17.165

3.  In vivo selection of populations of Plasmodium chabaudi chabaudi AS resistant to a monoclonal antibody that reacts with the precursor to the major merozoite surface antigen.

Authors:  J C Wood; J C Sales de Aguiar; W Jarra; S A Ogun; G Snounou; K N Brown
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

4.  Monoclonal antibodies that protect in vivo against Plasmodium chabaudi recognize a 250,000-dalton parasite polypeptide.

Authors:  D B Boyle; C I Newbold; C C Smith; K N Brown
Journal:  Infect Immun       Date:  1982-10       Impact factor: 3.441

5.  Potentiating effect of pyrimethamine and sulfadoxine against dihydrofolate reductase from pyrimethamine-sensitive and pyrimethamine-resistant Plasmodium chabaudi.

Authors:  W Sirawaraporn; Y Yuthavong
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

6.  Resistance of a rodent malaria parasite to a thymidylate synthase inhibitor induces an apoptotic parasite death and imposes a huge cost of fitness.

Authors:  Francis W Muregi; Isao Ohta; Uchijima Masato; Hideto Kino; Akira Ishih
Journal:  PLoS One       Date:  2011-06-16       Impact factor: 3.240

7.  Possible pitfalls in the identification of glycophorin-binding proteins of Plasmodium falciparum.

Authors:  M R van Schravendijk; R J Wilson; C I Newbold
Journal:  J Exp Med       Date:  1987-08-01       Impact factor: 14.307

Review 8.  Melatonin signaling and its modulation of PfNF-YB transcription factor expression in Plasmodium falciparum.

Authors:  Wânia Rezende Lima; Anthony A Holder; Célia R S Garcia
Journal:  Int J Mol Sci       Date:  2013-07-01       Impact factor: 5.923

9.  A well-conserved Plasmodium falciparum var gene shows an unusual stage-specific transcript pattern.

Authors:  Sue A Kyes; Zoe Christodoulou; Ahmed Raza; Paul Horrocks; Robert Pinches; J Alexandra Rowe; Chris I Newbold
Journal:  Mol Microbiol       Date:  2003-06       Impact factor: 3.501

10.  Biosynthesis and processing of a Plasmodium falciparum schizont antigen recognized by immune serum and a monoclonal antibody.

Authors:  A A Holder; R R Freeman
Journal:  J Exp Med       Date:  1982-11-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.